Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon
Hospital finance

More financial challenges ahead for not-for-profit hospitals

"Margins are not expected to return to pre-pandemic levels for quite some time," according to a new report.

Thumbnail

High costs limit the value of dapagliflozin, empagliflozin as heart failure treatments

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more. 

Biden’s budget: Extend Medicare solvency through higher taxes on rich, more drug price changes

Biden says his proposals are an extension of what he has already accomplished to reduce the deficit and lower healthcare spending.

MercyOne completes acquisition of Genesis

The deal was first announced in September 2022, and with its closure, all interests and operations of Genesis become part of MercyOne.

Thumbnail

Eli Lilly caps insulin costs at $35 per month

The company announced price reductions of 70% for its most commonly prescribed insulins.

Medicare money payment physician

Hospitals still facing financial struggles in 2023

Hospital margins were -1% in January 2023, compared to -0.7% in December 2022. 

 

Doctor at computer

Hospital CEO turnover is on the rise

The number of CEO changes at U.S. companies rose 12% from December 2022 to January 2023, with hospital CEOs playing a key part in that trend. 

Pfizer in talks to acquire Seagen in deal worth more than $30B

Pharmaceutical giant Pfizer is reportedly in talks to acquire Seagen, a biotechnology company focused on developing cancer therapies.

Displaying 337 - 344 of 2290

Around the web

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Cardiovascular Business
Cardiology groups cheer new bill that would improve access to Medicare claims data

If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup